Earnings call transcript: Xero reports strong growth, stock dips on margin concerns in H2 2026

Xero posted FY2026 operating revenue of NZD 2.75 billion, up 31% year on year, with adjusted EBITDA rising 18% to NZD 757 million and customers increasing to 4.92 million. Gross margin fell to 83.9% as Melio was integrated, and the stock dropped 8.59% on profitability and margin concerns despite strong growth. Management guided FY2027 revenue to NZD 3.62-3.73 billion and adjusted EBITDA to NZD 860-920 million, while highlighting AI, payments, and U.S. expansion as key growth drivers.

Analysis

The market’s negative read is about sequencing, not the headline growth. Xero is effectively choosing to convert operating momentum into a larger, more durable monetization stack while temporarily depressing visible margin quality through payments integration and U.S. brand spend. That usually creates a valuation air pocket: fundamental upgrades don’t re-rate until investors see the incremental dollars turn into cleaner operating leverage, so the next few quarters are likely to be driven more by margin cadence than revenue beats.

The most important second-order effect is that the mix shift toward payments and AI changes the business model from seat-based SaaS to a more transactional platform. That should support higher customer lifetime value, but it also makes near-term gross margin ratios less useful and raises the bar for execution because payments revenue is more scale-sensitive and partner-dependent. In practice, the U.S. brand investment and integrated GTM create a deferred payoff profile: if retention and attach rates hold, CAC payback can improve; if not, the market will treat the spend as pro-cyclical rather than strategic.

Consensus seems to be underestimating how much of the current selloff is a “proof gap,” not a deterioration in underlying demand. The risk is that investors anchor on pro forma margin compression and ignore the fact that management is explicitly trading a few quarters of reported efficiency for a larger addressable pool and higher monetization density. Conversely, the upside catalyst is any evidence that AI and payments are lifting ARPC without accelerating churn, because that would force a higher-quality growth multiple even before full margin normalization.

For competitors, the clearest pressure is on other SMB software vendors that still rely primarily on subscription expansion; Xero is moving toward a more hybrid model with more monetization levers. That makes it harder for lower-featured incumbents to defend pricing if Xero’s bundled AI and payments tools improve workflow stickiness. The market may also be underpricing the optionality in the U.S. channel shift: if direct acquisition and brand awareness compound, the long-run economics can improve faster than the model currently implies.

Key Decisions for Investors

• Initiate a tactical long in XRO on a 3-6 month horizon, sized as a valuation/re-rating trade rather than a momentum trade; target a rebound if the next update confirms ARPC and retention stability, with a stop if margin dilution widens faster than guided.
• Pair trade: long XRO / short a slower-growth SMB SaaS peer with weaker payments attach or no AI distribution optionality over the next 2 quarters; the trade works if the market starts rewarding hybrid monetization over pure subscription growth.
• Buy 6-9 month call spreads on XRO only on post-earnings weakness, to capture a potential re-rate from “margin concern” to “platform monetization” while limiting downside if U.S. brand spend disappoints.
• For event-driven accounts, avoid chasing the selloff outright; wait for the first quarter where payments revenue and AI monetization appear in the bridge, because that is the inflection point that can compress the bear case.
• Monitor for a catalyst in the next 1-2 quarters: any evidence that the new spend is improving U.S. conversion or reducing churn would support adding to longs; absent that, keep position size modest because the market will likely punish delayed payoff.